GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CEL-SCI Corp (FRA:LSRM) » Definitions » Other Gross PPE

CEL-SCI (FRA:LSRM) Other Gross PPE : €17.45 Mil (As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is CEL-SCI Other Gross PPE?

CEL-SCI's Other Gross PPE for the quarter that ended in Mar. 2024 was €17.45 Mil.

CEL-SCI's quarterly Other Gross PPE declined from Sep. 2023 (€27.05 Mil) to Dec. 2023 (€18.32 Mil) and declined from Dec. 2023 (€18.32 Mil) to Mar. 2024 (€17.45 Mil).

CEL-SCI's annual Other Gross PPE increased from Sep. 2021 (€27.56 Mil) to Sep. 2022 (€30.77 Mil) but then declined from Sep. 2022 (€30.77 Mil) to Sep. 2023 (€27.05 Mil).


CEL-SCI Other Gross PPE Historical Data

The historical data trend for CEL-SCI's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CEL-SCI Other Gross PPE Chart

CEL-SCI Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Other Gross PPE
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.15 20.74 27.56 30.77 27.05

CEL-SCI Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.49 20.31 27.05 18.32 17.45

CEL-SCI Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


CEL-SCI (FRA:LSRM) Business Description

Traded in Other Exchanges
Address
8229 Boone Boulevard, Suite 802, Vienna, VA, USA, 22182
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The company is focused on activating the immune system to fight cancer and infectious diseases. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.

CEL-SCI (FRA:LSRM) Headlines

No Headlines